Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jasmine Zeki"'
Autor:
Kimberly J. Ornell, Jordan S. Taylor, Jasmine Zeki, Naohiko Ikegaki, Hiroyuki Shimada, Jeannine M. Coburn, Bill Chiu
Publikováno v:
Cancer Medicine, Vol 9, Iss 8, Pp 2891-2903 (2020)
Abstract Immunotherapy targeting GD2 is a primary treatment for patients with high‐risk neuroblastoma. Dinutuximab is a monoclonal antibody with great clinical promise but is limited by side effects such as severe pain. Local delivery has emerged a
Externí odkaz:
https://doaj.org/article/01e8782bbfaf4100ba124fadbc3a0521
Autor:
Bill Chiu, Sheri L. Spunt, James C.Y. Dunn, Kathleen M. Sakamoto, Norman J. Lacayo, Florette K. Hazard, Matias Bruzoni, Enrico Danzer, Jordan S. Taylor, Garry L. Coles, Nathan Sumarsono, Jasmine Zeki, Min Huang
Neuroblastoma is a deadly pediatric solid tumor with infrequent recurrent somatic mutations. Particularly, the pathophysiology of tumors without MYCN amplification remains poorly defined. Utilizing an unbiased approach, we performed gene set enrichme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0978b1bfa756c0bbd8dcb526b67e56
https://doi.org/10.1158/0008-5472.c.6512389
https://doi.org/10.1158/0008-5472.c.6512389
Autor:
Bill Chiu, Sheri L. Spunt, James C.Y. Dunn, Kathleen M. Sakamoto, Norman J. Lacayo, Florette K. Hazard, Matias Bruzoni, Enrico Danzer, Jordan S. Taylor, Garry L. Coles, Nathan Sumarsono, Jasmine Zeki, Min Huang
Supplementary Fig. S1. Elevated mRNA expression of TERT and TERT-associated genes in NB with TERT gene rearrangement. Supplementary Fig. S2. Effects of dinaciclib on genome-wide chromatin occupancy of epigenetic modulators in CLB-GA cells. Supplement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::151349ab7d931c0dcebd9e77803a20b8
https://doi.org/10.1158/0008-5472.22426582.v1
https://doi.org/10.1158/0008-5472.22426582.v1
Autor:
Jordan S. Taylor, Hiroyuki Shimada, Jeannine M. Coburn, Jasmine Zeki, Naohiko Ikegaki, Kimberly J. Ornell, Bill Chiu
Publikováno v:
Cancer Medicine, Vol 9, Iss 8, Pp 2891-2903 (2020)
Cancer Medicine
Cancer Medicine
Immunotherapy targeting GD2 is a primary treatment for patients with high‐risk neuroblastoma. Dinutuximab is a monoclonal antibody with great clinical promise but is limited by side effects such as severe pain. Local delivery has emerged as a poten
Autor:
Florette K. Hazard, Matias Bruzoni, Norman J. Lacayo, Jordan S. Taylor, Nathan Sumarsono, Enrico Danzer, Sheri L. Spunt, Kathleen M. Sakamoto, Garry L. Coles, Jasmine Zeki, Bill Chiu, James C.Y. Dunn, Min Huang
Publikováno v:
Cancer Research. 80:1024-1035
Neuroblastoma is a deadly pediatric solid tumor with infrequent recurrent somatic mutations. Particularly, the pathophysiology of tumors without MYCN amplification remains poorly defined. Utilizing an unbiased approach, we performed gene set enrichme
Autor:
Naohiko Ikegaki, Jeannine M. Coburn, Jamie Harris, Jordan S. Taylor, Jasmine Zeki, Ryan Deaton, Burcin Yavuz, Lingdao Sha, Hiroyuki Shimada, Bill Chiu, Amit Sethi, David L. Kaplan, Peter H. Gann
Publikováno v:
J Pediatr Surg
Purpose Large cell neuroblastomas (LCN) are frequently seen in recurrent, high-risk neuroblastoma but are rare in primary tumors. LCN, characterized by large nuclei with prominent nucleoli, predict a poor prognosis. We hypothesize that LCN can be cre
Autor:
Jasmine Zeki, Naohiko Ikegaki, Burcin Yavuz, Bill Chiu, Jordan S. Taylor, David L. Kaplan, Jeannine M. Coburn, Kristin Harrington
Publikováno v:
J Pharm Sci
Neuroblastoma is the most common extra-cranial childhood tumor and current treatment requires surgical resection and multi-drug chemotherapy. Local, perioperative delivery of chemotherapeutics is a promising treatment method for solid tumors that req
Autor:
Rachel L Greathouse, Bill Chiu, Min Huang, John P. O'Bryan, Modupeola Diyaolu, Jasmine Zeki, Vinodh Rajagopalan
Publikováno v:
Journal of the American College of Surgeons. 233:S189-S190
Autor:
Jordan S. Taylor, Jasmine Zeki, Miao Gong, Lauren Wood, Min Huang, Bill Chiu, Hiroyuki Shimada
Publikováno v:
J Pediatr Surg
Introduction High-risk neuroblastoma is a deadly disease; poor prognosticators are MYCN-amplification and TERT-overexpression. We hypothesized that Gene Set Enrichment Analysis (GSEA) could identify pathways associated with MYCN-amplification and tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd1fddc26e94a3a411ff0e8aae9e8f32
https://europepmc.org/articles/PMC8225564/
https://europepmc.org/articles/PMC8225564/
Autor:
Jordan S. Taylor, Jeannine M. Coburn, Jasmine Zeki, David L. Kaplan, Naohiko Ikegaki, Bill Chiu, Burcin Yavuz
Publikováno v:
Surgery. 164:909-915
PURPOSE: Advanced stage neuroblastoma patients require multi-agent chemotherapy. Intra-tumoral implantation of vincristine-loaded silk gel utilizes local diffusion to decrease orthotopic neuroblastoma tumor growth in mice. We hypothesize that injecti